Recursion Pharmaceuticals
clinical patient population large and diagnosable no approved medical therapy disease overview cerebral cavernous malformations | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
86 of 143
Related slides by other companies
CARGO Therapeutics
IPO
March 2024
for patients whose disease to car cell therapy lead product candidate could address a significant and growing unmet need cargo | CARGO Therapeutics
Alkermes
Results
June 2022
artistry in combination with | Alkermes
Kymera
Investor Presentation
June 2023
disease characteristics | Kymera
AstraZeneca
Investor Event
June 2023
lung | AstraZeneca
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io